VYNE Therapeutics
VYNE
VYNE
64 hedge funds and large institutions have $20.1M invested in VYNE Therapeutics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
69% less capital invested
Capital invested by funds: $64M → $20.1M (-$43.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holding in Top 10
–
Calls
$140K
Puts
$32K
Top Buyers
| 1 | +$1.3M | |
| 2 | +$151K | |
| 3 | +$128K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$76.3K |
| 5 |
Two Sigma Investments
New York
|
+$47.6K |
Top Sellers
| 1 | -$4.79M | |
| 2 | -$557K | |
| 3 | -$499K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$426K |
| 5 |
Axa
Paris,
France
|
-$423K |